Clinical importance of the lncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors.
Joseph S TokerJ Bryan IorgulescuAlexander L LingGenaro Rodriguez VillaJosephina A M A GadetLaxmi ParidaGad A GetzCatherine J WuDavid A ReardonE Antonio ChioccaMarco MineoPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These findings suggest an association between NEAT1 expression and patient response to anti-PD-1/PD-L1 therapy in melanoma and GBM and have important implications for the role of lncRNAs in the tumor microenvironment.